Gentamicin – Injection products

Exceptions or additions to the recognized standards. For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:Acinetobacter spp.Other Non-Enterobacterales Content current as of: 10/23/2025...

Fosfomycin Injection

S = Susceptible; I = Intermediate; R = Resistanta. Susceptibility interpretive criteria are based on a dose of 6 grams fosfomycin every 8 hours by intravenous infusion over 1 hour in patients with an estimated creatinine clearance of 50 mL/min.b. For disk diffusion,...

Guidance Recap Podcast

PodcastThank you for joining us for another episode of the Guidance Recap Podcast. My name is Kylie Haskins, and I am today’s host. In this episode, I am excited to be talking with two people from FDA’s Center for Drug Evaluation and Research, Dr. David Reasner, the...

Completed BsUFA II Deliverables

Best Practices for Communication Between IND Sponsors and FDA During Drug DevelopmentFinal Guidance Updated guidance on best practices for communication between IND sponsors and FDA during drug development.Meeting Management Goals12/29/2017BsUFA II: Assessment of the...

CDER International Program

Contents:  Mission and PurposeThe Center for Drug Evaluation and Research (CDER) has a mission to ensure the availability of safe and effective medicines to improve public health in the United States. Recognizing that pharmaceutical development, manufacturing, and...